NIH-funded research R01 grant

Using tiny robots to deliver cancer treatment directly to the lungs

Official title: Aerosolized microbots as a platform for targeted lung therapy

Funded at Colorado School of Mines · NIH-11132406 · Data updated 2026-11-12

This study is exploring a new way to treat lung cancer using tiny robots that you can breathe in, which deliver medicine right to the cancer cells in your lungs, aiming to make treatment more effective and with fewer side effects.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionColorado School of Mines
NIH-funded
Lab location1 site (Golden, United States)
Project startApril 1, 2025
Project endJanuary 31, 2029
Funding year2025
Award (this year)$416,796
NIH project number1R01EB037377-01A1
Project IDNIH-11132406 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with lung cancer, particularly those in advanced stages requiring chemotherapy.

Less likely to help

Patients with early-stage lung cancer or those not requiring chemotherapy may not benefit from this research.

What this research studies

This research investigates a novel approach to lung cancer treatment by utilizing aerosolized microbots that can be inhaled and assembled within the lungs. These microbots are designed to carry chemotherapeutic agents directly to cancerous cells, minimizing the side effects associated with traditional chemotherapy. The project aims to optimize the delivery of these microbots using magnetic fields to ensure they reach the targeted areas within the lung. By focusing on specific locations, the goal is to enhance the effectiveness of the treatment while reducing systemic toxicity.

Why it matters

Potential benefit: If successful, this research could significantly improve lung cancer treatment outcomes by providing targeted therapy that reduces harmful side effects.

How similar studies have gone: While the use of microbots for drug delivery is a novel approach, similar targeted delivery methods have shown promise in other areas of cancer treatment.

Where this research is happening

  • Colorado School of Mines
    Golden, United States
    Active

Researchers

  • Principal investigator: Marr, David Wm — Colorado School of Mines
  • Study coordinator: Marr, David Wm

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.